Changes include a black box warning. In addition, a “Dear Healthcare Professional” letter was sent that explained the changes in the labeling, gave proper prescribing information, and discussed the problems associated with the drug.
And for oxycontin
Concerned about growing numbers of reports of diversion and abuse of the drug oxycontin, FDA strengthened the warnings and precautions sections in the labeling of the prescription drug used to treat moderate to severe pain.
Oct 31, 2001
Recommended
Recommended
Machinery Basics
Annual Outlook Report: Workforce
Hiring remains a major challenge in packaging, with 78% struggling to fill unskilled roles and 84% lacking experienced workers. As automation grows, companies must rethink hiring and training. Download the full report for key insights.
Download Now
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
